Literature DB >> 28189274

Heart-Type Fatty Acid Binding Protein and Ischemia-Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft Surgery.

Matthias Thielmann1, Susanne Pasa2, Torulv Holst2, Daniel Wendt2, Daniel-Sebastian Dohle2, Ender Demircioglu2, Vikram Sharma3, Heinz Jakob2.   

Abstract

BACKGROUND: Heart-type fatty acid binding protein (hFABP) and ischemia-modified albumin (IMA) have been put forward as novel biomarkers to detect myocardial injury shortly after onset of ischemia. We compared hFABP and IMA with cardiac troponin I (cTnI) for speed and reliability in the diagnosis of perioperative myocardial infarction (PMI) after coronary artery bypass graft surgery (CABG).
METHODS: In all, 210 consecutive patients undergoing isolated CABG with cardiopulmonary bypass were enrolled in a prospective study. Blood samples were taken perioperatively and throughout the first 72 hours after surgery; clinical data and events were recorded. In cohort A, serum concentrations of hFABP and cTnI were measured using a combined quantitative bedside assay. In cohort B, IMA and cTnI serum concentrations were measured using an albumin cobalt binding test. Perioperative myocardial infarction was defined using a cTnI cutoff of greater than 10.5 ng/mL occurring within 24 hours of CABG or new electrocardiographic changes.
RESULTS: In cohort A, 14 patients were identified with PMI (group 1), whereas 94 had no PMI and served as controls (group 2). Both hFABP and cTnI were increased in group 1 as compared with group 2 (p < 0.001). Although cTnI did not differ before 12 hours, hFABP diverged much earlier, at 1 hour postoperatively (p < 0.001). An hFABP concentration of 20 μg/mL at 1 hour detected PMI with an area under the curve of 77.1%. In cohort B, 18 patients were identified with PMI (group 3), and 84 patients served as controls (group 4). No difference in cTnI values could be observed between the groups until 12 hours postoperatively. Ischemia-modified albumin failed to differentiate at any postoperative time point; the low discriminative power of IMA was confirmed with an area under the curve of 53.3% at 1 hour, 48.5% at 6 hours, and 39.3% at 12 hours postoperatively.
CONCLUSIONS: Heart-type fatty acid binding protein is a sensitive and rapid biomarker that detected PMI reliably at 1 hour after CABG, much earlier than cTnI. The diagnostic value of IMA for detection of PMI appears to be very limited in this setting.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28189274     DOI: 10.1016/j.athoracsur.2016.10.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

Review 1.  Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: A review.

Authors:  Viola Weidenmann; N Bryce Robinson; Lisa Q Rong; Irbaz Hameed; Ajita Naik; Mahmoud Morsi; Philippe Grieshaber; Andreas Böning; Leonard N Girardi; Mario Gaudino
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

2.  [Changes of myocardial calcium currents in rats with myocardial injury induced by running exercise during acute hypoxia].

Authors:  Q Dan; J Bai; Z Cai; K Lin; Y Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

3.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

Review 4.  [New cardiac biomarkers for early detection of myocardial infarction in cardiac surgery].

Authors:  Sebastian Roth; Giovanna Lurati Buse
Journal:  Anaesthesist       Date:  2021-05-04       Impact factor: 1.041

5.  ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.

Authors:  Matthias Thielmann; Vikram Sharma; Nawwar Al-Attar; Heerajnarain Bulluck; Gianluigi Bisleri; Jeroen Bunge; Martin Czerny; Péter Ferdinandy; Ulrich H Frey; Gerd Heusch; Johannes Holfeld; Petra Kleinbongard; Gudrun Kunst; Irene Lang; Salvatore Lentini; Rosalinda Madonna; Patrick Meybohm; Claudio Muneretto; Jean-Francois Obadia; Cinzia Perrino; Fabrice Prunier; Joost P G Sluijter; Linda W Van Laake; Miguel Sousa-Uva; Derek J Hausenloy
Journal:  Eur Heart J       Date:  2017-08-14       Impact factor: 29.983

6.  Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study.

Authors:  Danica Marković; Tatjana Jevtović-Stoimenov; Vladan Ćosić; Biljana Stošić; Vesna Dinić; Bojana Marković-Živković; Radmilo J Janković
Journal:  J Med Biochem       Date:  2018-04-01       Impact factor: 3.402

7.  The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and Albumin-Adjusted Ischemia-Modified Albumin During Cardiopulmonary Bypass.

Authors:  Seyda Efsun Ozgunay; Kadir Kaan Ozsin; Yasemin Ustundag; Derya Karasu; Buket Ozyaprak; Burak Balcı; Ozcan Erel; Senol Yavuz
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

8.  Oxidative Stress in Patients before and after On-Pump and Off-Pump Coronary Artery Bypass Grafting: Relationship with Syntax Score.

Authors:  Petar Vukicevic; Aleksandra Klisic; Vojislava Neskovic; Luka Babic; Aleksandar Mikic; Natasa Bogavac-Stanojevic; Milos Matkovic; Vladimir Milićević; Nemanja Aleksic; Jelena Kotur-Stevuljevic
Journal:  Oxid Med Cell Longev       Date:  2021-07-30       Impact factor: 6.543

9.  Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Authors:  Mehmet Kirişci; Aydemir Koçarslan; Duygun Altintaş Aykan; Filiz Alkan Baylan; Adem Doğaner; Yavuz Orak
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

Review 10.  Ischemia-Modified Albumin: Origins and Clinical Implications.

Authors:  Alla Shevtsova; Iuliia Gordiienko; Viktoriia Tkachenko; Galyna Ushakova
Journal:  Dis Markers       Date:  2021-07-19       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.